By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Bronchodilator combinations > Utibron neohaler
Bronchodilator combinations

Utibron neohaler

https://themeditary.com/drug/utibron-neohaler-18641.html
Medically Reviewed by Philip Thornton, DipPharm TheMediTary.Com | Reviewed: Sep 26, 2023  Additional Content by TheMediTary.Com

Generic name: glycopyrrolate and indacaterol (inhalation) [ glye-koe-pir-oh-late-and-in-da-ka-ter-ol ]

Drug class: Bronchodilator combinations

Dosage form: inhalation capsule

Availability: Discontinued

Pregnancy & Lactation: Risk data available

Brand names: Utibron neohaler

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Utibron neohaler?

Utibron inhalation powder contains a combination of glycopyrrolate and indacaterol. Glycopyrrolate is an anticholinergic. Indacaterol is a bronchodilator. These medications work by relaxing muscles in the airways to improve breathing.

Utibron Neohaler is used long term to prevent airflow obstruction or bronchospasm in people with COPD (chronic obstructive pulmonary disease).

Utibron Neohaler is not for use in treating asthma.

Indacaterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Talk with your doctor about your individual risk.

Warnings

You should not use Utibron Neohaler if you are allergic to glycopyrrolate, indacaterol, milk proteins, or if you have asthma.

Utibron Neohaler is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack.

Indacaterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Utibron Neohaler is not for use in treating asthma.

Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.

How should I take Utibron neohaler

Use Utibron Neohaler exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides.

Utibron Neohaler is not a rescue medicine for bronchospasm attacks. Use only fast-acting inhalation medicine for an attack. Seek medical attention if your breathing problems get worse quickly, or if you think your medications are not working as well.

Read and follow all patient instructions provided with the inhaler device. Ask your doctor or pharmacist if you do not understand these instructions.

Utibron Neohaler is a powder that comes with a special inhaler device and blister packs containing capsules of the medicine. You will load one capsule into the inhaler device each time you use the medicine. Pushing the buttons on the side of the Neohaler device will pierce the capsule and release the medicine into the inhaler chamber.

Do not swallow the capsule or place it in your mouth. The capsule is for use only with the Neohaler inhalation device.

Use only the inhaler device provided with your medicine or you may not get the correct dose. Use the new inhaler each time you get your prescription refilled.

You should not stop using this medicine suddenly. Stopping suddenly may make your condition worse.

Store at room temperature away from moisture, heat, and light. Keep the inhaler device in the sealed foil tray until ready to start using it.

Dosing information

Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance:

-1 inhalation (glycopyrrolate 15.6 mcg-indacaterol 27.5 mcg) orally TWICE a day (in the morning and in the evening)

Comments:
-For each inhalation, administer the content of 1 capsule using the Neohaler device.
-More frequent administration or a greater number of inhalations (more than 1 capsule twice a day) is not recommended. Do not use 2 capsules at one time.

Detailed Utibron Neohaler dosage information
Utibron neohaler Dosage information (more detail)

Before Taking

You should not use Utibron Neohaler if you are allergic to glycopyrrolate or indacaterol or if you have:

  • allergy to milk proteins; or

  • asthma.

To make sure Utibron Neohaler is safe for you, tell your doctor if you have ever had:

  • heart disease, high blood pressure;

  • a seizure;

  • liver or renal disease;

  • glaucoma;

  • diabetes;

  • a thyroid disorder;

  • bladder obstruction or other urination problems; or

  • any food or drug allergies.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

You should not breastfeed while using Utibron Neohaler.

This medicine is not approved for use by anyone younger than 18 years old.

Utibron Neohaler pregnancy and breastfeeding warnings (more detail)

What happens if I miss a dose?

Use the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not use two capsules at one time. Do not use more than 2 capsules in one 24-hour period.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include chest pain, fast and irregular heartbeat, tremor, increased blood pressure, headache, and nervousness.

What should I avoid while using Utibron neohaler?

Do not use a second inhaled bronchodilator that contains indacaterol or a similar medicine (such as arformoterol, formoterol, olodaterol, salmeterol, or vilanterol).

Utibron neohaler side effects

Get emergency medical help if you have signs of an allergic reaction to Utibron Neohaler: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

  • worsening of your condition;

  • tremors, nervousness, chest pain, fast or pounding heartbeats;

  • wheezing, choking, or other breathing problems after using this medicine;

  • painful or difficult urination, or urinating more often;

  • blurred vision, tunnel vision, eye pain or redness, or seeing halos around lights;

  • high blood sugar - increased thirst, increased urination, dry mouth, fruity breath odor; or

  • low potassium level - leg cramps, constipation, irregular heartbeats, fluttering in your chest, numbness or tingling, muscle weakness or limp feeling.

Common Utibron Neohaler side effects may include:

  • back pain;

  • runny nose, sore throat; or

  • high blood pressure.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Utibron neohaler Side Effects

What other drugs will affect Utibron neohaler?

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Many drugs can interact with glycopyrrolate and indacaterol. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

More about Utibron neohaler (Glycopyrrolate and indacaterol (inhalation) [ glye-koe-pir-oh-late-and-in-da-ka-ter-ol ])

Dosage information
Utibron neohaler Side Effects
During pregnancy
Drug images
Side effects
Drug class: Bronchodilator combinations

Related treatment guides

COPD, Maintenance
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by